Give us your opinion on our latest poll, and see what your colleagues are saying. You can see the results of our previous surveys here as well.
Prenatal Use of Triptans Does Not Increase Risk of Autism, ADHD in Children
Triptans are often a first-line treatment for migraine and can be used to treat menstrual migraine and cluster headaches.
The Common Trends in Hepatitis Vaccine Uptake, Hesitancy
During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.
Majority of Americans Understand Risks of Increased Acetaminophen Usage
Acetaminophen exposure can increase the risk of perforation, ulceration, bleeding, heart failure, hypertension, and chronic kidney disease.
Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025
NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.
FDA Grants Expanded Interchangeability Designation to Yuflyma
Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.
FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body
The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.